Ahmed E. Elesawy

518 citations
19 papers · 429 indexed · h-index 11
Topics
MicroRNA in disease regulation (10 papers)Circular RNAs in diseases (6 papers)RNA Interference and Gene Delivery (3 papers)
Partner nations
EgyptSaudi ArabiaOman

In The Last Decade

Ahmed E. Elesawy

17 papers receiving 428 citations

Peers

Ahmed E. Elesawy
Comparison fields: 5 of 58
  • Cancer Research 304
  • Molecular Biology 290
  • Oncology 56
  • Epidemiology 49
  • Surgery 49
Replace Jiaomeng Pan with:
Jiaomeng Pan China
Jianshan Mao China
Fang Cui China
Shijun Wang China
Jiaxiang Ye China
Wanfeng Zhang China
Dan‐Ming Wei China
Haifan Xu China
Zhilong Yan China
Ahmed E. Elesawy relative to Jiaomeng Pan China Jiaomeng Pan's profile →
Citations per field
00.5×4.2×
Jiaomeng Pan · 1×
Citations per year

Countries citing papers authored by Ahmed E. Elesawy

Since Specialization
Citations

This map shows the geographic impact of Ahmed E. Elesawy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed E. Elesawy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed E. Elesawy more than expected).

Fields of papers citing papers by Ahmed E. Elesawy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed E. Elesawy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed E. Elesawy. The network helps show where Ahmed E. Elesawy may publish in the future.

Co-authorship network of co-authors of Ahmed E. Elesawy

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed E. Elesawy. A scholar is included among the top collaborators of Ahmed E. Elesawy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed E. Elesawy. Ahmed E. Elesawy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 1
5 3
6 2
7 7
8 6
9 18
10 54
11 27
12 28
13 49
14 17
15 11
16 76
17 52
18 51
19 25

About Ahmed E. Elesawy

Ahmed E. Elesawy is a scholar working on Cancer Research, Nephrology and Reproductive Medicine, having authored 19 papers that have together received 429 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (6 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Cancer Research (304 citations), Molecular Biology (290 citations) and Oncology (56 citations). Ahmed E. Elesawy has collaborated with scholars based in Egypt, Saudi Arabia and Oman. Frequent co-authors include Ahmed S. Doghish, Mohammed S. Elballal, Mahmoud A. Elrebehy, Ola Elazazy, Reem K. Shahin, Heba M. Midan, Al-Aliaa M. Sallam, Ahmed I. Abulsoud, Abdullah M. M. Elbadry and Sherif S. Abdel Mageed. Their work appears in journals such as Experimental Cell Research, Life Sciences and International Journal of Biological Macromolecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026